Age equal or above 65 years Clinical underlyng conditions indicating influenza vaccination Influenza,
Conditions
Interventions
Influenza vaccination for patients with currently recorgnized Influenza vaccination.
We use VAXIGRIP Susp inj/0,
5ml (R)(Sanofi).
Each patient receive one dose 0.5ml subcutaneous or intramuscular
Vaccin constitutiuon is adapted each year. In 2016-
2017,
vaccin constituion is: A/California/7/2009 (H1N1)pdm09 -
souche analogue (A/California/7/2009,
NYMC X-
179A) 15 µg HA** A/Hong Kong/4801/2014 (H3N2) -
souche analogue (A/Hong Kong/4801/2014,
263B) 15 µg HA** B/Brisbane/60/2008 -
souche analogue (B/Brisbane/60/2008,
type sauvage) 15 µg HA
Experimental Drug
Influenza vaccination
Sponsors
None
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Age equal or above 65 years Clinical underlyng conditions indicating influenza vaccination
Exclusion criteria
Exclusion criteria: Patients with life-threatening conditions, Upper function disorder Non-French speaking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Influenza vaccination coverage at the end of the vaccination period for each epidemic period Patients interviews | — |
Secondary
| Measure | Time frame |
|---|---|
| Time Interval quality indicator - Length of stay continuous monitoring of time quality indicator during the study period Electronic medical record | — |
Countries
France
Contacts
Public ContactChristophe Choquet
Assitance Publique Hopitaux de Paris
Outcome results
None listed